πŸ‡ΊπŸ‡Έ FDA
Patent

US 11541125

Noncrushable pill formulations

granted A61KA61K31/485A61K47/59

Quick answer

US patent 11541125 (Noncrushable pill formulations) held by The Regents of the University of California expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/485, A61K47/59, A61K47/60, A61K47/64